Veeva Systems || OpenData Abzena Ltd
Enquire now and stand a chance to win exclusive gifts!
Enquire now and stand a chance to win exclusive gifts!
Enquire now and stand a chance to win exclusive gifts!
Enquire now and stand a chance to win exclusive gifts!
Enquire now and stand a chance to win exclusive gifts!
Enquire now and stand a chance to win exclusive gifts!
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

26

Jul 2021

ImaginAb announces extension of long-standing partnership with Boehringer Ingelheim

ImaginAb Inc a market leading global biotechnology company focused on developing next generation immuno oncology imaging agents and therapeutic radiopharmaceuticals RPT today announced the signing of a new significant multiyear nonexclusive license agreement with Boehringer Ingelheim

26

Jul 2021

Sun Pharma and Cassiopea SpA Announce Signing of License and Supply Agreements for Winlevi® (clascoterone cream 1%) in US and Canada

Sun Pharmaceutical Industries Ltd Sun Pharma and includes its subsidiaries andor associate companies and Cassiopea SpA a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action MOA to address longstanding essential dermatological...

23

Jul 2021

Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Spain

Acorda Therapeutics Inc today announced that it has entered into distribution and supply agreements with Esteve Pharmaceuticals SA ESTEVE to commercialize INBRIJA mg levodopa inhalation powder hard capsules in Spain INBRIJA is indicated in the EU for the intermittent treatment of episodic motor flu...

23

Jul 2021

Pfizer Provides Update on U.S. FDA Review of Abrocitinib and XELJANZ® Filings

Pfizer Inc announced today that the US Food and Drug Administration FDA has notified the company that it will not meet the Prescription Drug User Fee Act PDUFA goal dates for the New Drug Application for abrocitinib for the treatment of adults and adolescents with moderate to severe atopic dermatiti...

press releasesRead more...

26

Jul 2021

Saniona Receives U.S. FDA Orphan Drug Designation for Tesomet in Hypothalamic Obesity

Saniona a clinical stage biopharmaceutical company focused on rare diseases today announced that the US Food and Drug Administration FDA has granted orphan drug designation to Tesomet for the treatment of hypothalamic obesity HO Tesomet is the first and only investigational treatment for HO to recei...

26

Jul 2021

Fidia announces the FDA Orphan Drug designation for ONCOFID®-P for the treatment of malignant mesothelioma, the cancer caused by exposure to asbestos

Fidia Farmaceutici an Italian company world leader in the research development formulation and commercialization of hyaluronic acidbased products announced today that the US Food and Drug Administration has granted Orphan Drug Designation for ONCOFIDP for the treatment of malignant mesothelioma MM a...

26

Jul 2021

Allarity Therapeutics and Lantern Pharma Enter into Agreement for Future Clinical Development of Irofulven

Allarity Therapeutics AS Allarity and Lantern Pharma Inc Lantern today announced that they have entered into an exclusive agreement under which Lantern will reacquire global rights to Irofulven LP and assume full authority to manage and guide future clinical development and commercialization Irofulv...

24

Jul 2021

DALVANCE® (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients

AbbVie announced that the US Food and Drug Administration FDA approved DALVANCE dalbavancin for the treatment of acute bacterial skin and skin structure infections ABSSSI in pediatric patients from birth DALVANCE is the first singledose option administered as a minute intravenous IV infusion for the...

EventsRead more...

28 - 29

Jul 2021

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    ExpreS<sup>2</sup>ion Biotechnologies

    Vice President - Business Development

    ExpreSion Biotechnologies protein expression system ExpreS is an important protein expression tool in the scientists tool box for protein expression The ExpreS platform has demonstrated in many instances its usefulness in RD with several ExpreSmade proteins having now been crystallized
  • Articles

    Meet scientist Daria Donati

    Before I went I had preconceptions about what people can do But I met doctors there who could run a diagnosis without modern tools They dont have things like MRIs but they can look at you read your symptoms and tell you what illness you have I was exposed to different ways of thinking and solving problems

  • Research Insights

    General understanding on physical stability of pharmaceutical glasses

    Although amorphous solid dispersion is one of the most important formulation technologies for poorly soluble drugs the number of marketed oral amorphous formulations is still limited The lack of an accelerated study protocol for predicting crystallization behavior of amorphous forms has been one of the biggest issues that inhibit their wide use Isothermal crystallization behavior of pharmaceutical glasses is

  • Techno Trends

    ProteoTuner systems to directly investigate protein levels

    Clontech has developed the new ProteoTuner systems based on a technology developed by Dr Thomas Wandless and colleagues at Stanford University This is aimed to enable the direct investigation of a proteins functions a key focus in discoverybased cell biology research through direct manipulation of the proteins levels in vivo The range of ProteoTuner systems constitute...

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...